Tudriqev Injection, Suspension
Product Images NDC 83616-106

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tudriqev (NDC 83616-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Replimune, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1a (Tudriqev 01)

An instructional diagram showing a syringe injecting into a skin lesion at a shallow angle of less than 45 degrees. The illustration labels skin layers including epidermis, dermis, and subcutaneous tissue, and notes that the injection entry point may be within or away from the tumor site.*

FDA Label Image

Figure 1b (Tudriqev 02)

An instructional diagram showing a top-down view of skin illustrating two injection approaches: on the left, the fanning injection approach with multiple directional arrows from a single injection site; on the right, multiple insertion sites with arrows indicating injection directions from two separate points.*

FDA Label Image

Figure 2a (Tudriqev 03)

An instructional diagram depicting a shallow intratumor injection at less than a 45-degree angle. It shows skin layers including ulcer, epidermis lesion, dermis, and subcutaneous tissue with a syringe injecting into or near a tumor site.*

FDA Label Image

Figure 2b (Tudriqev 04)

An instructional diagram showing a top-down view of skin with an ulcer and viable tumor. It illustrates the technique of injecting radially around the ulcer to achieve appropriate tumor coverage.*

FDA Label Image

Figure 3a (Tudriqev 05)

An illustration showing an intratumoral injection procedure into a liver. The diagram depicts a syringe injecting into a liver tumor, guided by an ultrasound probe emitting sound waves for imaging and accurate targeting.*

FDA Label Image

Figure 3b (Tudriqev 06)

An anatomical illustration showing the lungs with a tumor on the right lung. The image depicts an intratumoral injection being administered directly into the lung tumor with a syringe. Additional elements include a patient positioned on a scanning or imaging device, suggesting guidance or localization for the injection.*

FDA Label Image

Figure 4a (Tudriqev 07)

An anatomical illustration showing a liver with a targeted area. A medical device resembling an ultrasound probe is positioned on the liver surface, emitting signals. Two labeled needles are depicted: an introducer needle inserted into the liver mass and a primed Tudriqev needle connected below, indicating a procedure involving intratumor injection.*

FDA Label Image

Figure 4b (Tudriqev 08)

An instructional illustration showing the intratumoral injection of Tudriqev (vusolimogene oderparepvec-wtpg) into a lung tumor. The diagram depicts human lungs with a tumor on one side and a primed Tudriqev injection needle connected to an introducer needle delivering the medication directly into the tumor.*

FDA Label Image

Principal Display Panel (10^6 PFU/mL Vial Carton)

Packaging label for Tudriqev 10^6 PFU/mL injection, suspension for intratumor injection by Replimune, Inc. The carton contains a single-dose vial and includes storage instructions, active ingredient vusolimogene oderparepvec-wtpg, and directions to discard unused portions. The label emphasizes it is Rx only and provides manufacturer contact information.*

FDA Label Image

Principal Display Panel (10^7 PFU/mL Vial Carton)

Packaging label for Tudriqev (vusolimogene oderparepvec-wtpg) injection, suspension, 10^7 PFU/mL strength. The label indicates it is for intratumor injection only, single-dose vial, with one vial per carton. The labeler is Replimune, Inc. Storage instructions and contents are provided on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.